These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 16841080

  • 1. Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity.
    U'Ren L, Kedl R, Dow S.
    Cancer Gene Ther; 2006 Nov; 13(11):1033-44. PubMed ID: 16841080
    [Abstract] [Full Text] [Related]

  • 2. In vivo plasmid electroporation induces tumor antigen-specific CD8+ T-cell responses and delays tumor growth in a syngeneic mouse melanoma model.
    Kalat M, Küpcü Z, Schüller S, Zalusky D, Zehetner M, Paster W, Schweighoffer T.
    Cancer Res; 2002 Oct 01; 62(19):5489-94. PubMed ID: 12359758
    [Abstract] [Full Text] [Related]

  • 3. CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination.
    Cheng WF, Hung CF, Lin KY, Ling M, Juang J, He L, Lin CT, Wu TC.
    Gene Ther; 2003 Aug 01; 10(16):1311-20. PubMed ID: 12883527
    [Abstract] [Full Text] [Related]

  • 4. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K, Kontani K, Ozaki Y, Sawai S, Tezuka N, Nagata T, Fujino S, Itoh Y, Taguchi O, Koide Y, Asai T, Ohkubo I, Ogasawara K.
    Cancer Res; 2003 Nov 15; 63(22):7920-5. PubMed ID: 14633722
    [Abstract] [Full Text] [Related]

  • 5. Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects.
    Chen CA, Chang MC, Sun WZ, Chen YL, Chiang YC, Hsieh CY, Chen SM, Hsiao PN, Cheng WF.
    Gene Ther; 2009 Jun 15; 16(6):776-87. PubMed ID: 19357714
    [Abstract] [Full Text] [Related]

  • 6. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex.
    Garzón MR, Berraondo P, Crettaz J, Ochoa L, Vera M, Lasarte JJ, Vales A, Van Rooijen N, Ruiz J, Prieto J, Zulueta J, González-Aseguinolaza G.
    Vaccine; 2005 Feb 03; 23(11):1384-92. PubMed ID: 15661387
    [Abstract] [Full Text] [Related]

  • 7. CD4+ T cells are able to promote tumor growth through inhibition of tumor-specific CD8+ T-cell responses in tumor-bearing hosts.
    den Boer AT, van Mierlo GJ, Fransen MF, Melief CJ, Offringa R, Toes RE.
    Cancer Res; 2005 Aug 01; 65(15):6984-9. PubMed ID: 16061684
    [Abstract] [Full Text] [Related]

  • 8. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X, Yu C, Zhao J, Fu L, Yi S, Liu S, Yu T, Chen W.
    J Gene Med; 2007 Aug 01; 9(8):715-26. PubMed ID: 17595048
    [Abstract] [Full Text] [Related]

  • 9. Gene gun administration of therapeutic HPV DNA vaccination restores the efficacy of prolonged defrosted viral based vaccine.
    Lin CT, Yen CF, Shaw SW, Yen TC, Chen YJ, Soong YK, Lai CH.
    Vaccine; 2009 Dec 09; 27(52):7352-8. PubMed ID: 19781679
    [Abstract] [Full Text] [Related]

  • 10. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 09; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 11. DNA vaccine encoding heat shock protein 60 co-linked to HPV16 E6 and E7 tumor antigens generates more potent immunotherapeutic effects than respective E6 or E7 tumor antigens.
    Huang CY, Chen CA, Lee CN, Chang MC, Su YN, Lin YC, Hsieh CY, Cheng WF.
    Gynecol Oncol; 2007 Dec 09; 107(3):404-12. PubMed ID: 17905417
    [Abstract] [Full Text] [Related]

  • 12. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR, Holst PJ, Pircher H, Christensen JP, Thomsen AR.
    Eur J Immunol; 2009 Oct 09; 39(10):2725-36. PubMed ID: 19637230
    [Abstract] [Full Text] [Related]

  • 13. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
    Kim S, Lee JB, Lee GK, Chang J.
    Prostate; 2009 Jun 15; 69(9):938-48. PubMed ID: 19267351
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of vaccine-induced primary and memory CD8(+) T-cell responses by soluble PD-1.
    Song MY, Park SH, Nam HJ, Choi DH, Sung YC.
    J Immunother; 2011 Apr 15; 34(3):297-306. PubMed ID: 21389868
    [Abstract] [Full Text] [Related]

  • 15. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
    Wu A, Oh S, Gharagozlou S, Vedi RN, Ericson K, Low WC, Chen W, Ohlfest JR.
    J Immunother; 2007 Apr 15; 30(8):789-97. PubMed ID: 18049330
    [Abstract] [Full Text] [Related]

  • 16. Co-immunisation with DNA encoding RANK/RANKL or 4-1BBL costimulatory molecules does not enhance effector or memory CTL responses afforded by immunisation with a tumour antigen-encoding DNA vaccine.
    Herd KA, Wiethe C, Tindle RW.
    Vaccine; 2007 Jul 09; 25(28):5209-19. PubMed ID: 17544551
    [Abstract] [Full Text] [Related]

  • 17. Th2-dominated antitumor immunity induced by DNA immunization with the genes coding for a basal core peptide PDTRP and GM-CSF.
    Chu Y, Xia M, Lin Y, Li A, Wang Y, Liu R, Xiong S.
    Cancer Gene Ther; 2006 May 09; 13(5):510-9. PubMed ID: 16341143
    [Abstract] [Full Text] [Related]

  • 18. Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity.
    Kreiter S, Selmi A, Diken M, Koslowski M, Britten CM, Huber C, Türeci O, Sahin U.
    Cancer Res; 2010 Nov 15; 70(22):9031-40. PubMed ID: 21045153
    [Abstract] [Full Text] [Related]

  • 19. Vaccination with combination of Fit3L and RANTES in a DNA prime-protein boost regimen elicits strong cell-mediated immunity and antitumor effect.
    Song S, Liu C, Wang J, Zhang Y, You H, Wang Y, Liu F, Sun S.
    Vaccine; 2009 Feb 11; 27(7):1111-8. PubMed ID: 19100302
    [Abstract] [Full Text] [Related]

  • 20. Prophylactic and therapeutic intervention in IgE responses by biolistic DNA vaccination primarily targeting dendritic cells.
    Sudowe S, Ludwig-Portugall I, Montermann E, Ross R, Reske-Kunz AB.
    J Allergy Clin Immunol; 2006 Jan 11; 117(1):196-203. PubMed ID: 16387606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.